Janki Patel, MD
Gastroenterology · Encinitas, CANPI 1548606668
Payments from drug & device makers
Across 368 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$961
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$703
- Johnson & Johnson$579
- Bristol Myers Squibb$461
- Sanofi$405
- plus $2K from 30 others
What the payments were for
- Food & beverage$8,15599%
- Education$411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 139 | $3,148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $961 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 39 | $703 |
| Johnson & Johnson | 27 | $579 |
| Bristol Myers Squibb | 31 | $461 |
| Sanofi | 13 | $405 |
| Intercept Pharmaceuticals, Inc. | 9 | $196 |
| Lilly USA, LLC | 6 | $183 |
| Pfizer | 7 | $160 |
| QOL Medical, LLC | 8 | $155 |
| Merck | 6 | $111 |
| Madrigal Pharmaceuticals | 5 | $102 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
| Ferring Pharmaceuticals Inc. | 5 | $100 |
| Amgen | 3 | $91 |
| Celltrion USA Inc. | 3 | $86 |
| Novo Nordisk | 3 | $78 |
| Vivus LLC | 3 | $69 |
| Evoke Pharma, Inc. | 3 | $64 |
| Alfasigma USA, Inc. | 3 | $58 |
| Redhill Biopharma Inc. | 2 | $43 |
| Covidien LP | 1 | $40 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Biocon Biologics Inc | 1 | $35 |
| Eisai Inc. | 1 | $30 |
| Baxter Healthcare | 1 | $29 |
| Ironwood Pharmaceuticals, Inc | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $24 |
| Exact Sciences | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Organon | 1 | $18 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Biomerieux Inc | 1 | $10 |
| Micro-tech Endoscopy USA, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,196 in reported general payments places this provider in the 70th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 162 | $9,786 |
| Pantoprazole Sodium | 66 | $1,294 |
| CholestyramineCholestyramine (With Sugar) | 15 | $665 |
| Dicyclomine Hcl | 46 | $574 |
| Omeprazole | 73 | $528 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 28 | $315 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Encinitas
- Peter WinkleCypress$116.7M
- Manuchehr DaraniSanta Ana$17.7M
- Jatinder PruthiLancaster$4.4M
- Long DangWestminster$4.3M
- Muhammad SheikhFresno$4.3M
- Gregory WienerChula Vista$3.5M
- Gil MelmedLos Angeles$3M
- Christopher BowlusSacramento$3M
- Bennett RothLos Angeles$2.8M
- Brigid BolandSan Diego$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.